Published in Matrix Biol on October 01, 1997
p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma. J Clin Invest (1999) 1.19
Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins. J Cell Biol (2004) 1.17
Cross talk between beta(1) and alpha(V) integrins: beta(1) affects beta(3) mRNA stability. Mol Biol Cell (2001) 1.06
Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation. Am J Pathol (1998) 1.03
Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis. Mol Cancer Res (2013) 1.01
Regulation of mRNA and protein levels of beta1 integrin variants in human prostate carcinoma. Am J Pathol (2000) 1.00
Functional diversification between two related Plasmodium falciparum merozoite invasion ligands is determined by changes in the cytoplasmic domain. Mol Microbiol (2010) 0.96
IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels. PLoS One (2013) 0.93
Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways. Mol Biol Cell (2000) 0.92
Role of the beta3 integrin subunit in human primary melanoma progression: multifunctional activities associated with alpha(v)beta3 integrin expression. Am J Pathol (1998) 0.92
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors. Biol Open (2012) 0.91
Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit. Exp Cell Res (2011) 0.78
The novel α4B murine α4 integrin protein splicing variant inhibits α4 protein-dependent cell adhesion. J Biol Chem (2014) 0.76
beta 1C Integrin expression in human endometrial proliferative diseases. Am J Pathol (2003) 0.75
A novel mutation in β integrin reveals an integrin-mediated interaction between the extracellular matrix and cki-1/p27KIP1. PLoS One (2012) 0.75
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res (2000) 2.39
Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem (1987) 2.29
Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int (1990) 2.04
Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem (1990) 1.92
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J Cell Sci (1998) 1.70
Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res (1999) 1.66
An alternative cytoplasmic domain of the integrin beta 3 subunit. Proc Natl Acad Sci U S A (1989) 1.61
Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene (2006) 1.59
Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro. J Cell Biol (1987) 1.59
Integrins and prostate cancer metastases. Cancer Metastasis Rev (2001) 1.51
Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J Biol Chem (2000) 1.43
Inhibition of cell cycle progression by the alternatively spliced integrin beta 1C. Science (1995) 1.38
Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem (1997) 1.23
p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma. J Clin Invest (1999) 1.19
Interaction of fibronectin with cultured human endothelial cells: characterization of the specific receptor. Blood (1989) 1.18
Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem (1995) 1.07
High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc Natl Acad Sci U S A (1993) 1.06
Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma. Am J Pathol (1996) 1.06
The novel structural motif Gln795-Gln802 in the integrin beta 1C cytoplasmic domain regulates cell proliferation. J Biol Chem (1995) 1.05
Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation. Am J Pathol (1998) 1.03
The localization of a platelet GpIIb-IIIa-related protein in endothelial cell adhesion structures. Blood (1988) 1.03
The alpha v beta 3 integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor. J Biol Chem (1993) 1.01
Regulation of mRNA and protein levels of beta1 integrin variants in human prostate carcinoma. Am J Pathol (2000) 1.00
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. Br J Cancer (2011) 0.97
Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces. Blood (1996) 0.93
Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways. Mol Biol Cell (2000) 0.92
Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest (1993) 0.91
Integrin laminin receptor profile of pulmonary squamous cell and adenocarcinomas. Hum Pathol (1998) 0.90
Platelets express a membrane protein complex immunologically related to the fibroblast fibronectin receptor and distinct from GPIIb/IIIa. Blood (1987) 0.87
Down-regulation of beta(1C) integrin in breast carcinomas correlates with high proliferative fraction, high histological grade, and larger size. Am J Pathol (2000) 0.84
Role of TGF-beta 1 in experimental glomerulonephritis. Ciba Found Symp (1991) 0.84
Uptake of aspartate aminotransferase into mitochondria in vitro depends on the transmembrane pH gradient. Biochem J (1982) 0.83
Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog. Am J Physiol (1985) 0.81
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery. Thromb Res (1985) 0.79
Modulation of cell proliferation by the integrin cytoplasmic domain. Kidney Int (1997) 0.78
Platelet adhesion to subendothelium--effect of shear rate, hematocrit and platelet count on the dynamic equilibrium between platelets adhering to and detaching from the surface. Thromb Haemost (1985) 0.77
Epitope-specific antibodies to the beta(1C) integrin cytoplasmic domain variant. Exp Mol Pathol (2001) 0.77
Regulation of MCP-3 and BRCA2 mRNA expression levels by beta(1) integrins. Exp Mol Pathol (2001) 0.76
Prostacyclin and thromboxane levels during cardiac ischemia in dogs. Adv Prostaglandin Thromboxane Leukot Res (1985) 0.75
Expression of heterologous integrin genes. Methods Mol Biol (1999) 0.75
Application of polymerase chain reaction for the discovery of new adhesion molecule family members. Methods Mol Biol (1999) 0.75
Human platelet adhesion to subendothelium under controlled hemodynamic conditions: a methodological approach. Methods Find Exp Clin Pharmacol (1985) 0.75